4BMK
Serine Palmitoyltransferase K265A from S. paucimobilis with bound PLP- Myriocin Aldimine
Summary for 4BMK
| Entry DOI | 10.2210/pdb4bmk/pdb |
| Descriptor | SERINE PALMITOYLTRANSFERASE, PYRIDOXAL-5'-PHOSPHATE, Decarboxylated Myriocin, ... (5 entities in total) |
| Functional Keywords | transferase-antibiotic complex, transferase, external aldimine, inhibitor, sphingolipids, natural product, antibiotic isp-1, transferase/antibiotic |
| Biological source | SPHINGOMONAS PAUCIMOBILIS |
| Total number of polymer chains | 2 |
| Total formula weight | 96081.49 |
| Authors | Wadsworth, J.M.,Clarke, D.J.,McMahon, S.A.,Beattie, A.E.,Lowther, J.,Dunn, T.M.,Naismith, J.H.,Campopiano, D.J. (deposition date: 2013-05-09, release date: 2013-09-04, Last modification date: 2023-12-20) |
| Primary citation | Wadsworth, J.M.,Clarke, D.J.,Mcmahon, S.A.,Lowther, J.P.,Beattie, A.E.,Langridge-Smith, P.R.R.,Broughton, H.B.,Dunn, T.M.,Naismith, J.H.,Campopiano, D.J. The Chemical Basis of Serine Palmitoyltransferase Inhibition by Myriocin. J.Am.Chem.Soc., 135:14276-, 2013 Cited by PubMed Abstract: Sphingolipids (SLs) are essential components of cellular membranes formed from the condensation of L-serine and a long-chain acyl thioester. This first step is catalyzed by the pyridoxal-5'-phosphate (PLP)-dependent enzyme serine palmitoyltransferase (SPT) which is a promising therapeutic target. The fungal natural product myriocin is a potent inhibitor of SPT and is widely used to block SL biosynthesis despite a lack of a detailed understanding of its molecular mechanism. By combining spectroscopy, mass spectrometry, X-ray crystallography, and kinetics, we have characterized the molecular details of SPT inhibition by myriocin. Myriocin initially forms an external aldimine with PLP at the active site, and a structure of the resulting co-complex explains its nanomolar affinity for the enzyme. This co-complex then catalytically degrades via an unexpected 'retro-aldol-like' cleavage mechanism to a C18 aldehyde which in turn acts as a suicide inhibitor of SPT by covalent modification of the essential catalytic lysine. This surprising dual mechanism of inhibition rationalizes the extraordinary potency and longevity of myriocin inhibition. PubMed: 23957439DOI: 10.1021/JA4059876 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (1.62 Å) |
Structure validation
Download full validation report






